Company: SPRB
Filing Date: 2025-10-17
Form Type: 8-K
Source: 0001193125-25-242488
Chunk: 0

Company: SPRUCE BIOSCIENCES, INC.
Filing Date: 2025-10-17
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Director Departure

On October 15, 2025, Bali Muralidhar, Ph. D. notified Spruce Biosciences, Inc. (the “ Company”) of his resignation as a member of the Company’s board of directors (the “ Board”) and as a member of the compensation committee of the Board, effective immediately. Dr. Muralidhar’s resignation is not the result of any disagreement with the Company on any matter relating to its operations, policies, practices or otherwise.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  Spruce Biosciences, Inc.                                             
  By:                           /s/ Samir Gharib                       
                                Samir Gharib                           
                                President and Chief Financial Officer